Mean age, HbA1c, BMI, diabetes duration, BP, lipid profile, obesity staging categories and smoking rates were similar, as were proportions on lipid‐lowering medication and insulin between AMOS trial groups. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.